Defining B Cell Epitopes of Ovalbumin for the C57BL/6 Mice Immunized with Recombinant Mycobacterium smegmatis

  • Kim, Hyo-Joon (Department of Biochemistry and Molecular Biology, College of Sciences, Hanyang University) ;
  • Lee, Yang-Min (Department of Biochemistry and Molecular Biology, College of Sciences, Hanyang University) ;
  • Hwang, Joon-Sung (Department of Biochemistry and Molecular Biology, College of Sciences, Hanyang University) ;
  • Won, Ho-Shik (Department of Chemistry, College of Sciences, Hanyang University) ;
  • Kim, Bok-Hwan (Department of Environmental Health, Faculty of Natural Science, Korea National Open University)
  • Received : 1999.05.06
  • Accepted : 1999.05.31
  • Published : 1999.09.30

Abstract

Recombinant Mycobacterium smegmatis expressing ovalbumin was used to immunize C57BL/6(H-$2^b$) mice, and the humoral immunity against recombinant ovalbumin was analyzed. Antibodies were purified by denatured ovalbumin-conjugated affinity chromatography. The epitopes of the antibodies were screened with a random peptide library displayed on the tip of fUSE5 filamentous phage pIII minor coat proteins. Two peptides, IRLADR and SPGAEV, were selected predominantly by the recognition of purified antibodies using biopanning methods. The composition of the peptide sequence with the primary structure of OVA revealed that the peptide sequence analogizes to INEAGR, part of the $^{323}ISQAVHAAHAEINEAGR^{339}$ sequence previously reported as the antigenic determinant for murine Band also Th cell epitopes (I-$A^d$ binding). Also, the structures of these mimotopes obtained from restrained molecular dynamic computations resulted in the formation of a $\beta$-turn proven to be a secondary structure of the parent peptide within the ovalbumin molecule, enabling us to confirm the structural similarity. This study demonstrates that immunization with recombinant M. smegmatis can generate neutralizing antibodies identical with those induced by the administration of natural antigenic proteins and supports the potential use of mycobacteria as vaccine delivery vehicles.

Keywords